Clopidogrel Versus Aspirin as Chronic Maintenance Antiplatelet Monotherapy in Patients After Percutaneous Coronary Intervention With Chronic Kidney Disease: A Post Hoc Analysis of the HOST‐EXAM Trial
During the chronic maintenance period after coronary stenting, the risk of thrombotic and bleeding events was significantly higher in patients with CKD compared with those without CKD. There was no statistical difference in the treatment effect of clopidogrel monotherapy in those with versus without CKD.
Authors
- Kyung Woo Park (ORCID: https://orcid.org/0000-0003-2432-4432)
- Jung‐Kyu Han (ORCID: https://orcid.org/0000-0002-0016-0747)
- Jeehoon Kang (ORCID: https://orcid.org/0000-0002-9078-2231)
- Tae‐Ho Park (ORCID: https://orcid.org/0000-0002-9968-8276)
- In‐Ho Chae (ORCID: https://orcid.org/0000-0003-1644-2105)
- Hyo‐Soo Kim (ORCID: https://orcid.org/0000-0003-0847-5329)
- Han‐Mo Yang (ORCID: https://orcid.org/0000-0002-1548-2351)
- Minju Han (ORCID: https://orcid.org/0000-0002-0748-287X)
- Bon‐Kwon Koo (ORCID: https://orcid.org/0000-0002-8188-3348)
- Eun‐Seok Shin (ORCID: https://orcid.org/0000-0002-9169-6968)
- H. K. Lee (ORCID: https://orcid.org/0009-0004-5930-2705)
- Yong Hoon Kim (ORCID: https://orcid.org/0000-0002-9669-3598)
- Bum‐Soo Kim (ORCID: https://orcid.org/0000-0002-3870-6813)
- Sang‐Hyeon Park (ORCID: https://orcid.org/0000-0001-8453-4146)
- Won‐Yong Shin
- Ju Hyeon Oh (ORCID: https://orcid.org/0009-0003-0323-9041)
- Doyeon Hwang
Institutions
- Kangwon National University (KR)
- Samsung (South Korea) (KR)
- Soonchunhyang University (KR)
- Dong-A University Hospital (KR)
- Seoul National University Hospital (KR)
- Seoul National University Bundang Hospital (KR)
- Kangbuk Samsung Hospital (KR)
- Ulsan University Hospital (KR)
- Sungkyunkwan University (KR)
Publication Details
- Journal
- Journal of the American Heart Association
- Published
- 2024-09-09
- DOI
- https://doi.org/10.1161/jaha.124.035269
- Citations
- 3
- Primary Topic
- Antiplatelet Therapy and Cardiovascular Diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.21